[HTML][HTML] Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia

EM Salem, T Yar, AO Bamosa… - Saudi Journal of …, 2010 - journals.lww.com
Materials and Methods: The study was conducted on 88 adult patients attending King Fahd
Hospital of the University, Al-Khobar, Saudi Arabia, from 2007 to 2008, with dyspeptic …

[PDF][PDF] Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline-comparison of three 3-year studies

F Siavashi, P Saniei, NS LATIFI, S Maserat… - 2010 - sid.ir
Background: Antimicrobials have been useful in the treatment of H. pylori-related dyspeptic
diseases. However, emergence of resistant strains often decreases the eradication rates of …

Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapy

CH Kuo, SSW Wang, WH Hsu, FC Kuo, BC Weng… - …, 2010 - Wiley Online Library
Objectives: The prospective study was designed to clarify the impact of CYP2C19 on
quadruple therapies and survey the efficacies of rabeprazole‐based quadruple therapy for …

Clarithromycin resistance and point mutations in the 23S rRNA gene in Helicobacter pylori isolates from Malaysia

SL HO, EL Tan, CK Sam… - Journal of digestive …, 2010 - Wiley Online Library
OBJECTIVE: To determine the prevalence of primary clarithromycin resistance amongst
Helicobacter pylori (H. pylori) strains in Malaysian patients with gastroduodenal diseases, by …

Efficacy of 1‐week proton pump inhibitor triple therapy as first‐line Helicobacter pylori eradication regime in Asian patients: Is it still effective 10 years on?

CS QUA, J Manikam, KL GOH - Journal of digestive diseases, 2010 - Wiley Online Library
OBJECTIVE: To re‐examine the efficacy and tolerability of 1‐week proton pump inhibitor
triple therapy as a first‐line Helicobacter pylori (H. pylori) eradication therapy. METHODS …

A randomized controlled trial: efficacy and safety of azithromycin, ofloxacin, bismuth, and omeprazole compared with amoxicillin, clarithromycin, bismuth, and …

M Minakari, AH Davarpanah Jazi, A Shavakhi… - …, 2010 - Wiley Online Library
Background: Helicobacter pylori infection of the stomach is widespread among human
populations and is considered to play a major role in the pathogenesis of various diseases …

[HTML][HTML] Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial

J Bago, K Majstorović, Ž Belošić-Halle… - Annals of Clinical …, 2010 - Springer
Introduction Antibiotic resistance decreases success of Helicobacter pylori (Hp) eradication.
Recently published results show low rate of resistance and better compliance with …

Increasing trend of metronidazole resistance in the treatment of Helicobacter pylori infection: A global challenge

N Buta, NF Tanih, RN Ndip - African Journal of Biotechnology, 2010 - ajol.info
Increasing trend of metronidazole resistance in the treatment of Helicobacter pylori infection: A
global challenge Page 1 African Journal of Biotechnology Vol. 9(8), pp. 1115-1121, 22 …

米非司酮联合利凡诺中期妊娠引产100 例临床观察

闻琴 - 中国医药指南, 2010 - cqvip.com
目的观察利凡诺羊膜腔内注射联合米非司酮终止中期妊娠的效果. 方法选择孕16~ 27
周自愿终止妊娠, 并行利凡诺引产的健康孕妇100 例. 随机分在两组, 试验组用利凡诺羊膜腔内 …

含莫西沙星三联疗法对幽门螺杆菌根除失败的补救治疗

郑小丽, 许乐 - 中华医学杂志, 2010 - cqvip.com
目的评价含莫西沙星的三联疗法补救治疗幽门螺杆菌(Hp) 的有效性和安全性. 方法将Hp
感染经常规三联疗法治疗失败的109 例患者按随机数字表分为A 组(53 例) 和B 组(56 例). A …